Role of CXCL13 in the formation of the meningeal tertiary lymphoid organ in multiple sclerosis [version 2; referees: 2 approved]
Immunomodulatory therapies available for the treatment of patients with multiple sclerosis (MS) accomplish control and neutralization of peripheral immune cells involved in the activity of the disease cascade but their spectrum of action in the intrathecal space and brain tissue is limited, taking i...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
F1000 Research Ltd
2018-09-01
|
| Series: | F1000Research |
| Online Access: | https://f1000research.com/articles/7-514/v2 |